Potential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level

被引:7
作者
Barac, Ioana S. [1 ]
Iancu, Mihaela [2 ]
Vacaras, Vitalie [1 ]
Cozma, Angela [3 ]
Negrean, Vasile [3 ]
Sampelean, Dorel [3 ]
Muresanu, Dafin F. [1 ]
Procopciuc, Lucia M. [4 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm Cluj Napoca, Dept Clin Neurosci, Cluj Napoca 400000, Romania
[2] Iuliu Hatieganu Univ Med & Pharm Cluj Napoca, Dept Med Informat & Biostat, Fac Med, Cluj Napoca 400012, Romania
[3] Iuliu Hatieganu Univ Med & Pharm Cluj Napoca, Dept Internal Med, Cluj Napoca 400000, Romania
[4] Iuliu Hatieganu Univ Med & Pharm Cluj Napoca, Dept Biochem, Cluj Napoca 400000, Romania
关键词
Il-23R; IL-27; rs181206; rs153109; rs11209026; multiple sclerosis; prognosis; INFLAMMATORY BOWEL DISEASES; HELPER; 17; CELLS; RECEPTOR GENE; RS11209026; POLYMORPHISM; RS153109; PROGRESSIVE FORMS; ALLELE PROMOTES; PROTECTIVE ROLE; IL23R GENE; INTERLEUKIN-27;
D O I
10.3390/jcm11010037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
(1) Background: interleukin 23 (IL-23) and interleukin 27 (IL-27) modulate the activity of T helper 17 cells (Th17) with critical roles in autoimmune diseases and multiple sclerosis (MS). The genes responsible for cytokine generation are highly influenced by the presence of single nucleotide polymorphisms (SNP) in main regions such as regulatory sequences or in promoter regions, contributing to disease susceptibility and evolution. The present study analyzed the associations of IL-23 and IL-27 SNPs with susceptibility to multiple sclerosis. (2) Methods: We performed a case-control study including 252 subjects: 157 patients diagnosed with MS and 95 controls. We used polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to determine the genotypes for IL-27 T4730C (rs 181206), IL-27 A964G (rs 153109), and IL-23 receptor gene (IL-23R) G1142A (rs 11209026). (3) Results: The IL27-T4730C gene polymorphism was significantly associated with an increased odds of MS under the dominant genetic model (TC + CC variant genotypes, adjusted odds ratio OR = 4.06, 95% CI: 2.14-7.83, p-value = 0.000007, Q-value = 0.000063). Individuals carrying the IL-27 A924G variant (AG + GG) genotype presented higher odds of MS compared to non-carriers under the dominant model (adjusted OR = 1.93, 95% CI: 1.05-3.51, p-value = 0.0324, Q-value = 0.05832) and the allelic genetic model (unadjusted p-value = 0.015, OR = 1.58, 95% CI: 1.09-2.28), while IL-23-R381Q SNP conferred a decreased odds of MS under a codominant model of inheritance (adjusted OR = 0.26, 95% CI: 0.08-0.92, p-value = 0.0276, Q-value = 0.058) and an allelic model (unadjusted p-value = 0.008, OR = 0.23, 95% CI: 0.07-0.75). In an additive model with adjustment for age group (<= 40 years vs. >40 years), sex and smoking, patients carrying the G-C (A964G, T4730C) haplotype had a 3.18 increased risk (95% CI: 1.74-5.81, p < 0.001) to develop multiple sclerosis. (4) Conclusions: The results of the current study showed a significant relationship of IL-27-A964G and IL-27-T4730C polymorphisms with increased risk of MS, and also the protective role of the IL-23-R381Q polymorphism. Moreover, the haplotype-based analysis proposed the mutant G-C (A924G, T4730C) as a significant risk haplotype for the development of MS.
引用
收藏
页数:17
相关论文
共 84 条
  • [1] Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review
    Abdollahi, Elham
    Tavasolian, Fataneh
    Momtazi-Borojeni, Amir Abbas
    Samadi, Morteza
    Rafatpanah, Houshang
    [J]. JOURNAL OF IMMUNOTOXICOLOGY, 2016, 13 (03) : 286 - 300
  • [2] A new focal model resembling features of cortical pathology of the progressive forms of multiple sclerosis: Influence of innate immunity
    Anabel Silva, Berenice
    Celeste Leal, Maria
    Isabel Farias, Maria
    Carlos Avalos, Juan
    Hilda Besada, Cristina
    Juan Pitossi, Fernando
    Cintia Ferrari, Carina
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2018, 69 : 515 - 531
  • [3] Anber Nahla, 2020, Novel Research in Microbiology Journal, V4, P613, DOI 10.21608/nrmj.2020.73434
  • [4] Multiple sclerosis - behind the immunity curtains
    Barac, I. S.
    Vacaras, V.
    Cozma, A.
    Procopciuc, L. M.
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (04) : 368 - 374
  • [5] IL27 T4730C Polymorphism and Serology in Multiple Sclerosis: A Pilot Study
    Barac, Ioana S.
    Vacaras, Vitalie
    Cozma, Angela
    Valeanu, Madalina
    Decea, Nicoleta
    Muresanu, Dafin F.
    Procopciuc, Lucia M.
    [J]. IN VIVO, 2021, 35 (05): : 2845 - 2853
  • [6] IL-12 FAMILY CYTOKINES: GENERAL CHARACTERISTICS, PATHOGENIC MICROORGANISMS, RECEPTORS, AND SIGNALLING PATHWAYS
    Behzadi, Payam
    Behzadi, Elham
    Ranjbar, Reza
    [J]. ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2016, 63 (01) : 1 - 25
  • [7] Quantitative trait loci analysis using the false discovery rate
    Benjamini, Y
    Yekutieli, D
    [J]. GENETICS, 2005, 171 (02) : 783 - 789
  • [8] Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
    Brucklacher-Waldert, Verena
    Sturner, Klarissa
    Kolster, Manuela
    Wolthausen, Julia
    Tolosa, Eva
    [J]. BRAIN, 2009, 132 : 3329 - 3341
  • [9] Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population
    Chae, Soo-Cheon
    Li, Chun-Shi
    Kim, Ki Mo
    Yang, Ji Yeon
    Zhang, Qinggao
    Lee, Yong-Chul
    Yang, Yun-Sik
    Chung, Hun-Taeg
    [J]. JOURNAL OF HUMAN GENETICS, 2007, 52 (04) : 355 - 361
  • [10] Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
    Chen, Y
    Langrish, CL
    Mckenzie, B
    Joyce-Shaikh, B
    Stumhofer, JS
    McClanahan, T
    Blumenschein, W
    Churakovsa, T
    Low, J
    Presta, L
    Hunter, CA
    Kastelein, RA
    Cua, DJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) : 1317 - 1326